Pharmacy News

Today's Pharmaceutical and Pharmacy News

Daily News Topic:

FDA News

3/10/10 - Abbott gets FDA approval for implantable lens

NORTH CHICAGO, Ill. The company received approval for the Tecnis multifocal 1-Piece intraocular lens for cataract patients. Intraocular lenses are implanted in a patient's eye after the removal of the natural lens that has become clouded by a cataract, the company said. Shares of Abbott rose 29 cents to $55.09 in afternoon trading.

3/10/10 - Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens

ABBOTT PARK, Ill., March 10Abbott announced today it has received U.S. Food and Drug Administration approval for the TECNISÂ® Multifocal 1-Piece intraocular lens for cataract patients with and without presbyopia. Intraocular lenses are implanted in a patient's eye after the removal of the natural lens that has become clouded by a cataract.

3/10/10 - Allergan wins FDA approval for spasticity drug

Allergan, a multi-specialty healthcare company, has reported that the FDA has approved Botox for the treatment of increased muscle stiffness in the elbow, wrist and fingers in adults with upper limb spasticity. According to Allergan, Botox is a prescription-only medical product that contains tiny amounts of highly purified botulinum toxin protein r

3/10/10 - BOTOXÂ® (OnabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults

Allergan, Inc. today announced that the United States Food and Drug Administration has approved BOTOXÂ® for the treatment of increased muscle stiffness in the elbow, wrist and fingers in adults with upper limb spasticity. Spasticity is a debilitating condition impacting approximately 1 million Americans1, many of whom suffer from spasticity in the

3/10/10 - Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results

NASHVILLE, Tenn., March 10 Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on the hospital acute care and gastroenterology markets, today announced full year 2009 financial results. "The approval and launch of Caldolor and our initial public offering made 2009 a pivotal year for Cumberland," said A.J. Kazimi, Chief Execu

3/10/10 - FDA Approvals: Allergan, Abbott

The Food and Drug Administration said late yesterday that it has approved the use of Allergan's Botox to treat spasticity in elbow, wrist and finger muscles. Allergan will now be allowed to market Botox typically use to relax facial wrinkles for use in treating spastic muscles. The drug has already been used to treat neck spasms and eye muscle issu

Chain Drug Review

Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.

Featured Article from Chain Drug Review:

AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more